Literature DB >> 3929905

Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.

J el-On, L Weinrauch, R Livshin, Z Even-Paz, G P Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3929905      PMCID： PMC1416671          DOI： 10.1136/bmj.291.6497.704

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Treatment of diffuse cutaneous leishmaniasis with chlorpromazine ointment.

Authors:  T H Henriksen; S Lende
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

2.  Recurrent cutaneous leishmaniasis.

Authors:  R A Strick; M Borok; H C Gasiorowski
Journal:  J Am Acad Dermatol       Date:  1983-09       Impact factor: 11.527

3.  Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.

Authors:  J El-On; G P Jacobs; E Witztum; C L Greenblatt
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

4.  Cutaneous leishmaniasis: failure of topical treatment with imidazole derivatives in laboratory animals and man.

Authors:  L Weinrauch; R Livshin; G P Jacobs; J El-On
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  Treatment of leishmaniasis recidivens with intralesional injections of emetine hydrochloride: a case report.

Authors:  H A Cohen; A Wahaba
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437
  5 in total
  9 in total

Review 1.  Current therapies for treatment of cutaneous leishmaniasis in India.

Authors:  J Dogra
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

Review 2.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

Review 3.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

4.  Establish an allele-specific real-time PCR for Leishmania species identification.

Authors:  Yun Wu; Mengyuan Jiang; Shaogang Li; Nicholas R Waterfield; Guowei Yang
Journal:  Infect Dis Poverty       Date:  2022-06-02       Impact factor: 10.485

5.  Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

Authors:  S Frankenburg; D Glick; S Klaus; Y Barenholz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

6.  Ribosomes of Leishmania are a target for the aminoglycosides.

Authors:  M Maarouf; F Lawrence; S L Croft; M Robert-Gero
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

Review 7.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

Review 8.  Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.

Authors:  Marium Azim; Saeed Ahmad Khan; Saleem Ullah; Shafiq Ullah; Syed Ishtiaq Anjum
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

9.  Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics.

Authors:  Moran Shalev; Haim Rozenberg; Boris Smolkin; Abedelmajeed Nasereddin; Dmitry Kopelyanskiy; Valery Belakhov; Thomas Schrepfer; Jochen Schacht; Charles L Jaffe; Noam Adir; Timor Baasov
Journal:  Nucleic Acids Res       Date:  2015-08-11       Impact factor: 16.971
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.